淋巴结FDG摄取高增加口咽鳞癌远处转移风险
本研究纳入口咽鳞癌接受原发放疗的患者441例,分析治疗前FDG PET/CT中原发灶和淋巴结代谢参数在UICC8分期之外的预后价值。结果发现淋巴结FDG摄取对N部位和M部位复发有显著影响,HR分别为2.13和2.18,并提供了在线工具评估个体绝对风险。
要点
- 淋巴结FDG摄取高与N部位复发风险增加相关,HR 2.13(CI 1.20-3.77)。
- 淋巴结FDG摄取高与M部位复发风险增加相关,HR 2.18(CI 1.16-4.10)。
- 研究提供在线工具可评估个体四类事件的绝对风险。
核心结论
- 在竞争风险场景下,口咽鳞癌患者淋巴结FDG摄取高增加N部位和M部位复发风险。
研究设计与样本
- 纳入2010-2017年在Rigshospitalet接受原发放疗的口咽鳞癌患者441例,所有患者治疗前均行FDG PET/CT。
主要发现
- 淋巴结FDG摄取对N部位复发有显著影响,HR为2.13(CI 1.20-3.77)。
- 淋巴结FDG摄取对M部位复发有显著影响,HR为2.18(CI 1.16-4.10)。
临床怎么用
- 研究结果已整合为在线工具,可评估个体四类事件的绝对风险,帮助识别未来试验的候选者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to investigate if FDG uptake metrics in primary tumor and lymph node metastases in patients with oropharyngeal squamous cell carcinoma (OPSCC) has a prognostic value beyond UICC8 staging in a multiple endpoint model. METHODS: Patients with OPSCC treated with primary radiotherapy at Rigshospitalet in the period 2010-2017 were included. All patients had a pretreatment FDG PET/CT scan performed. Four cause-specific Cox regression models were built for the hazard ratios (HR) of recurrence in T-, N-, M-site, and death with no evidence of disease (NED), respectively. The following variables were included: T-, N-stage, p16 status, metabolic tumor volume, and FDG uptake in both primary tumor and lymph nodes. A competing risk analysis was performed and absolute risk estimates were estimated using the Aalen-Johansen method. RESULTS: Overall, 441 patients were included. Thirty-four patients had T-site recurrence, 31 N-site recurrence, 32 M-site recurrence, and 52 patients had death NED as event. Nodal FDG uptake had a significant impact on N- and M-site recurrence, with HRs of 2.13 (CI 1.20-3.77) and 2.18 (CI 1.16-4.10). The individual prognostication of absolute risk of the four events for any given patient can be assessed in the online tool (https://rasmussen.shinyapps.io/OPSCCmodelFDG_PET/). CONCLUSION: High nodal FDG uptake increases the risk of N- and M-site recurrence in patients with OPSCC in a competing risk scenario. The reported results are available in an easy applicable online tool and can help identify relevant candidates for future trials testing treatment approaches.
引用
- Jensen JS, Christensen JT, Håkansson K, et al. High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019. PMID: 31720757. doi:10.1007/s00259-019-04572-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。